Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ‘a community pharmacy model as a health promotion center for community members’. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

현재위치 : Home : 정보마당 : 정책동향
   
정보마당
의약품관련 행사
연구입찰공고 정책동향
해외정책동향
 
 
 
분     야 제목/내용
자료형태 저     자
구     분 국내    국외 출판사/기관명
  

번호 첨부 제목 저자명 출판사 조회
54 일본약사회 연차 보고서 .. Japanese Pharmaceutical Association 3022
53 IMS Generic Focus 2003 .. IMS Health 3138
52 Foreign Government Pharmaceutical Price and Access Controls .. Department of Commerce 2730
51 Competition and Regulation Issues in the Pharmaceutical Industry .. OECD 2732
50 Surveillance of Marketed Health Products in Canada .. Health Canada 3002
49 Sustaining Generic Medicines Markets in Europe Simons, S. & De Coster, S. Research Center for Pharmaceutical Care and Pharmaco-economics 2921
48 Annual Report of the European Medicines Agency 2006 .. EMEA 3222
47 Policies, Procedures and Methods: Used in the Pricing of Pharmaceutical Products .. [호주]Pharmaceutical Benefits Pricing Authority 2866
46 [캐나다]PMPRB(특허의약품심사위원회) Annual Report .. Patented Medicine Prices Review Board 3947
45 Pharmaceutical Pricing and Reimbursement Policy in Mexico Moise, P. & Docteur, E. OECD 3527

이전 10페이지 [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  다음 10페이지
 
 

서울 서초구 효령로194, 3층 (재)의약품정책연구소 TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

기부금 안내